SLC5A9

gene
On this page

Also known as SGLT4

Summary

SLC5A9 (solute carrier family 5 member 9, HGNC:22146) is a protein-coding gene on chromosome 1p33, encoding Sodium/glucose cotransporter 4 (Q2M3M2). Electrogenic Na(+)-coupled sugar symporter that may play a primary role in D-mannose and possibly D-fructose and D-glucose transport at the plasma membrane.

Predicted to enable D-glucose:sodium symporter activity. Predicted to be involved in hexose transmembrane transport. Located in extracellular exosome.

Source: NCBI Gene 200010 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 150 total
  • MANE Select transcript: NM_001011547

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:22146
Approved symbolSLC5A9
Namesolute carrier family 5 member 9
Location1p33
Locus typegene with protein product
StatusApproved
AliasesSGLT4
Ensembl geneENSG00000117834
Ensembl biotypeprotein_coding
OMIM620216
Entrez200010

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 5 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000236495, ENST00000425816, ENST00000438567, ENST00000441260, ENST00000471020, ENST00000493837, ENST00000525901, ENST00000527929, ENST00000532322, ENST00000533824, ENST00000906153, ENST00000906154

RefSeq mRNA: 2 — MANE Select: NM_001011547 NM_001011547, NM_001135181

CCDS: CCDS30709, CCDS44136

Canonical transcript exons

ENST00000438567 — 14 exons

ExonStartEnd
ENSE000007718584822885048228954
ENSE000007718594822929548229459
ENSE000007718624823194648232151
ENSE000019259704824733548248638
ENSE000035147804823572948235879
ENSE000035450344823365548233762
ENSE000035891754823154548231625
ENSE000036035204823767948237847
ENSE000036250404822472448224795
ENSE000036384224823236748232502
ENSE000036686434823060048230705
ENSE000036717694823932248239537
ENSE000036797774824245748242616
ENSE000039036934822271648222898

Expression profiles

Bgee: expression breadth ubiquitous, 171 present calls, max score 96.89.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4096 / max 191.2281, expressed in 49 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
27880.382544
27890.027115

Top tissues by expression

252 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ileal mucosaUBERON:000033196.89gold quality
jejunal mucosaUBERON:000039994.27gold quality
duodenumUBERON:000211491.29gold quality
kidney epitheliumUBERON:000481990.42gold quality
small intestine Peyer’s patchUBERON:000345489.09gold quality
small intestineUBERON:000210888.28gold quality
spermCL:000001983.49gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.01gold quality
right lungUBERON:000216781.79gold quality
right lobe of liverUBERON:000111481.53gold quality
epithelial cell of pancreasCL:000008380.06silver quality
sural nerveUBERON:001548879.95gold quality
tibial nerveUBERON:000132378.41gold quality
mucosa of stomachUBERON:000119978.12gold quality
body of pancreasUBERON:000115077.84gold quality
liverUBERON:000210777.51gold quality
adult mammalian kidneyUBERON:000008277.12gold quality
metanephros cortexUBERON:001053376.46gold quality
endocervixUBERON:000045876.27gold quality
kidneyUBERON:000211376.13gold quality
cortex of kidneyUBERON:000122575.77gold quality
upper lobe of left lungUBERON:000895275.55gold quality
jejunumUBERON:000211575.48gold quality
upper arm skinUBERON:000426375.30gold quality
upper lobe of lungUBERON:000894875.27gold quality
pancreatic ductal cellCL:000207975.25silver quality
apex of heartUBERON:000209874.56gold quality
left ovaryUBERON:000211974.56gold quality
cardiac muscle of right atriumUBERON:000337974.52gold quality
right ovaryUBERON:000211874.51gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.02

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

70 targeting SLC5A9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4262100.0073.263931
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-12118100.0065.881270
HSA-MIR-4481100.0066.421669
HSA-MIR-450099.9972.722367
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-548AN99.9770.912817
HSA-MIR-6888-3P99.9765.951170
HSA-LET-7D-5P99.9671.761632
HSA-MIR-445899.9671.641650
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-430299.8967.941187
HSA-MIR-3681-3P99.8870.462254

Literature-anchored findings (GeneRIF, showing 1)

  • SGLT4 would have unique physiological functions (i.e., absorption and/or reabsorption of Man, 1,5AG, and Fru, in addition to Glc). (PMID:15607332)

Cross-species orthologs

15 orthologs

OrganismSymbolGene ID
danio_rerioslc5a9ENSDARG00000005518
mus_musculusSlc5a9ENSMUSG00000028544
rattus_norvegicusSlc5a9ENSRNOG00000042950
drosophila_melanogasterCG2187FBGN0017448
drosophila_melanogasterrumpelFBGN0029950
drosophila_melanogasterSLC5A11FBGN0031998
drosophila_melanogasterbumpelFBGN0037895
drosophila_melanogasterChTFBGN0038641
drosophila_melanogastersaltFBGN0039872
drosophila_melanogasterSmvtFBGN0039873
drosophila_melanogasterCG31262FBGN0051262
drosophila_melanogasterCG31668FBGN0051668
drosophila_melanogasterCG33124FBGN0053124
drosophila_melanogasterkumpelFBGN0250757
caenorhabditis_elegansWBGENE00000501

Paralogs (12): SLC5A1 (ENSG00000100170), SLC5A4 (ENSG00000100191), SLC5A5 (ENSG00000105641), SLC5A7 (ENSG00000115665), SLC5A6 (ENSG00000138074), SLC5A2 (ENSG00000140675), SLC5A12 (ENSG00000148942), SLC5A10 (ENSG00000154025), SLC5A11 (ENSG00000158865), SLC5A3 (ENSG00000198743), SLC5A8 (ENSG00000256870), (ENSG00000293606)

Protein

Protein identifiers

Sodium/glucose cotransporter 4Q2M3M2 (reviewed: Q2M3M2)

Alternative names: Solute carrier family 5 member 9

All UniProt accessions (4): Q2M3M2, F8WD86, H0Y5P9, H0YC92

UniProt curated annotations — full annotation on UniProt →

Function. Electrogenic Na(+)-coupled sugar symporter that may play a primary role in D-mannose and possibly D-fructose and D-glucose transport at the plasma membrane. Transporter activity is driven by a transmembrane Na(+) electrochemical gradient set by the Na(+)/K(+) pump. Exclusively recognizes sugar substrates having a pyranose ring with an axial hydroxyl group on carbon 2.

Subcellular location. Cell membrane.

Tissue specificity. Expressed in the small intestine, kidney and liver.

Similarity. Belongs to the sodium:solute symporter (SSF) (TC 2.A.21) family.

Isoforms (3)

UniProt IDNamesCanonical?
Q2M3M2-11yes
Q2M3M2-22
Q2M3M2-33

RefSeq proteins (2): NP_001011547, NP_001128653 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001734Na/solute_symporterFamily
IPR018212Na/solute_symporter_CSConserved_site
IPR038377Na/Glc_symporter_sfHomologous_superfamily

Pfam: PF00474

Catalyzed reactions (Rhea), 1 shown:

  • D-mannose(out) + n Na(+)(out) = D-mannose(in) + n Na(+)(in) (RHEA:75475)

UniProt features (40 total): topological domain 14, transmembrane region 14, sequence variant 4, modified residue 2, splice variant 2, chain 1, region of interest 1, compositionally biased region 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q2M3M2-F183.540.54

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 604, 605

Glycosylation sites (1): 251

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-189200Cellular hexose transport
R-HSA-382551Transport of small molecules
R-HSA-425407SLC-mediated transmembrane transport

MSigDB gene sets: 93 (showing top): GOBP_CARBOHYDRATE_TRANSPORT, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN, GOBP_MONOATOMIC_CATION_TRANSPORT, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY, GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SYMPORTER_ACTIVITY

GO Biological Process (5): hexose transmembrane transport (GO:0008645), monoatomic ion transport (GO:0006811), sodium ion transport (GO:0006814), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085)

GO Molecular Function (7): low-affinity D-glucose:sodium symporter activity (GO:0005362), D-glucose:sodium symporter activity (GO:0005412), carbohydrate:monoatomic cation symporter activity (GO:0005402), hexose transmembrane transporter activity (GO:0015149), symporter activity (GO:0015293), solute:sodium symporter activity (GO:0015370), transmembrane transporter activity (GO:0022857)

GO Cellular Component (3): plasma membrane (GO:0005886), extracellular exosome (GO:0070062), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
SLC-mediated transmembrane transport1
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
solute:monoatomic cation symporter activity2
monosaccharide transmembrane transport1
metal ion transport1
sodium ion transport1
monoatomic cation transmembrane transport1
cellular process1
D-glucose:sodium symporter activity1
carbohydrate:monoatomic cation symporter activity1
solute:sodium symporter activity1
D-glucose transmembrane transporter activity1
carbohydrate transmembrane transporter activity1
hexose transmembrane transport1
monosaccharide transmembrane transporter activity1
secondary active transmembrane transporter activity1
sodium ion transmembrane transporter activity1
transporter activity1
transmembrane transport1
membrane1
cell periphery1
extracellular vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

831 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC5A9SLC2A2P11168554
SLC5A9SLC2A5P22732551
SLC5A9GARIN5AQ6IPT2533
SLC5A9SLC2A7Q6PXP3507
SLC5A9H7C1H1H7C1H1501
SLC5A9SLC2A11Q9BYW1501
SLC5A9WDR25Q64LD2493
SLC5A9SLC2A8Q9NY64461
SLC5A9TRABD2BA6NFA1460
SLC5A9FAM8A1Q9UBU6460
SLC5A9SLC25A45Q8N413452
SLC5A9ANKRD50Q9ULJ7451
SLC5A9SLC16A13Q7RTY0447
SLC5A9TPRA1Q86W33445
SLC5A9PDHA2P29803437

IntAct

7 interactions, top by confidence:

ABTypeScore
EGFRNDUFA4psi-mi:“MI:0914”(association)0.530
SLC5A9CD63psi-mi:“MI:0914”(association)0.530
KLF8psi-mi:“MI:0914”(association)0.350
NTRK1ILVBLpsi-mi:“MI:0914”(association)0.350
SLC5A9RER1psi-mi:“MI:0914”(association)0.350
SLC6A1CLGNpsi-mi:“MI:0914”(association)0.350

BioGRID (32): CD63 (Affinity Capture-MS), GIF (Affinity Capture-MS), SLC5A9 (Affinity Capture-MS), SLC5A9 (Affinity Capture-MS), SLC5A9 (Affinity Capture-MS), LPHN1 (Affinity Capture-MS), ATP5E (Affinity Capture-MS), USMG5 (Affinity Capture-MS), ATP5I (Affinity Capture-MS), ATP5H (Affinity Capture-MS), ATP5J (Affinity Capture-MS), CD63 (Affinity Capture-MS), CERS1 (Affinity Capture-MS), CHPT1 (Affinity Capture-MS), FZD8 (Affinity Capture-MS)

ESM2 similar proteins: A0PJK1, A8I1B9, A8WHP3, B9NAE4, D3ZIS0, O02228, O77741, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P41251, P49279, P49280, P53790, P53791, P53792, P53793, P53794, P56436, P70553, P83740, Q27946, Q27981, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q7T384, Q8BGY9, Q8C3K6, Q8K0E3, Q8UWF0, Q8VDT1

Diamond homologs: A0PJK1, A8I1B9, A8WHP3, D3ZIS0, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P53790, P53791, P53792, P53793, P53794, P96169, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q8C3K6, Q8K0E3, Q8VDT1, Q8WWX8, Q91ZP4, Q923I7, Q9ET37, Q9JKZ2, Q9NY91, Q9Z1F2, P31448

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

150 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance112
Likely benign14
Benign16

Top pathogenic / likely-pathogenic (0)

SpliceAI

2094 predictions. Top by Δscore:

VariantEffectΔscore
1:48222897:GG:Gdonor_gain1.0000
1:48222897:GGGT:Gdonor_loss1.0000
1:48222898:GG:Gdonor_gain1.0000
1:48222898:GGTA:Gdonor_loss1.0000
1:48222899:G:GGdonor_gain1.0000
1:48222900:T:Gdonor_loss1.0000
1:48224796:G:GGdonor_gain1.0000
1:48227893:G:GTdonor_gain1.0000
1:48227912:GACAT:Gdonor_gain1.0000
1:48227913:ACATA:Adonor_gain1.0000
1:48228960:G:GTdonor_gain1.0000
1:48231539:CCCCA:Cacceptor_loss1.0000
1:48231540:CCCAG:Cacceptor_loss1.0000
1:48231541:CCAG:Cacceptor_loss1.0000
1:48231542:CA:Cacceptor_loss1.0000
1:48231543:A:Tacceptor_loss1.0000
1:48231624:GG:Gdonor_gain1.0000
1:48231625:GG:Gdonor_gain1.0000
1:48231625:GGTA:Gdonor_loss1.0000
1:48231626:G:GAdonor_loss1.0000
1:48231627:T:Adonor_loss1.0000
1:48231631:G:GTdonor_gain1.0000
1:48232501:AGG:Adonor_loss1.0000
1:48232503:G:GAdonor_loss1.0000
1:48232503:G:GGdonor_gain1.0000
1:48232504:T:Adonor_loss1.0000
1:48233653:A:AGacceptor_gain1.0000
1:48233654:G:GGacceptor_gain1.0000
1:48233654:GAC:Gacceptor_gain1.0000
1:48233654:GACGA:Gacceptor_gain1.0000

AlphaMissense

4409 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:48237707:A:CS441R0.999
1:48237709:C:AS441R0.999
1:48237709:C:GS441R0.999
1:48232484:A:CS339R0.998
1:48232486:C:AS339R0.998
1:48232486:C:GS339R0.998
1:48235773:A:CS396R0.998
1:48235775:C:AS396R0.998
1:48235775:C:GS396R0.998
1:48235797:A:CS404R0.997
1:48235799:C:AS404R0.997
1:48235799:C:GS404R0.997
1:48228871:A:CS86R0.996
1:48228873:C:AS86R0.996
1:48228873:C:GS86R0.996
1:48228883:A:CS90R0.996
1:48228885:T:AS90R0.996
1:48228885:T:GS90R0.996
1:48228913:G:TG100W0.996
1:48228943:T:CF110L0.996
1:48228945:C:AF110L0.996
1:48228945:C:GF110L0.996
1:48235800:A:CS405R0.996
1:48235802:C:AS405R0.996
1:48235802:C:GS405R0.996
1:48228863:T:CL83P0.995
1:48233729:T:GY370D0.995
1:48237716:T:AW444R0.995
1:48237716:T:CW444R0.995
1:48237756:T:GF457C0.995

dbSNP variants (sampled 300 via entrez): RS1000013850 (1:48240702 A>C,T), RS1000139813 (1:48241128 T>C), RS1000223891 (1:48225553 C>T), RS1000256565 (1:48247646 C>G), RS1000339502 (1:48228657 C>T), RS1000447909 (1:48241716 C>T), RS1000895124 (1:48228420 G>A), RS1000925011 (1:48242026 C>G,T), RS1000953142 (1:48235045 G>A), RS1001017774 (1:48242282 T>C,G), RS1001067054 (1:48246904 C>T), RS1001179617 (1:48222293 CTT>C), RS1001285800 (1:48228765 C>T), RS1001297296 (1:48248872 T>TACA), RS1001474249 (1:48246046 T>C)

Disease associations

OMIM: gene MIM:620216 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST009391_1151Metabolite levels9.000000e-08
GCST009733_41Urinary metabolite levels in chronic kidney disease4.000000e-24
GCST010219_3Attention deficit hyperactivity disorder (inattention symptoms)1.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0010459aminoadipic acid measurement
EFO:0005116urinary metabolite measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Hexose transporter family

CTD chemical–gene interactions

34 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tetrachlorodibenzodioxindecreases expression, affects cotreatment4
Cyclosporinedecreases expression4
Aflatoxin B1decreases expression, decreases methylation, affects expression3
bisphenol Aaffects expression, affects cotreatment, decreases methylation2
Acetaminophendecreases expression2
Benzo(a)pyrenedecreases expression, affects methylation2
methyleugenoldecreases expression1
triphenyl phosphateaffects expression1
propionaldehydedecreases expression1
pirinixic acidaffects binding, decreases expression, increases activity1
sodium arsenitedecreases expression1
butyraldehydedecreases expression1
pentanaldecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic aciddecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Ethanolaffects cotreatment, increases expression1
Aldehydesdecreases expression1
Azathioprinedecreases expression1
Dimethyl Sulfoxideincreases expression1
Endosulfanaffects cotreatment, decreases expression1
Estradiolaffects cotreatment, increases expression1
Folic Acidaffects cotreatment, increases expression1
N-Nitrosopyrrolidinedecreases expression1
Nickeldecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Progesteroneaffects cotreatment, increases expression1
Quercetindecreases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4U7HuH7-SLC5A9-KO-c13Cancer cell lineMale
CVCL_D4U8HuH7-SLC5A9-KO-c7Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.